1/3/22 Innovate UK Biomedical Catalyst
Awarded a competitive Innovate UK Biomedical Catalyst grant of £0.9m.
Awarded a competitive Innovate UK Biomedical Catalyst grant of £0.9m.
Apeikon is extremely pleased to be awarded first prize in the Alderley Park Accelerator programme.
An article was published about Apeikon Therapeutics on the Science Entrepreneur Club. See: https://www.science-entrepreneur.com/blog-1/apeikon-therapeutics-tackling-the-side-effects-of-chemotherapy
Acceptance into the SETsquared ICURe programme. This 4-month programme is sponsored by Innovate UK, which focuses on bridging the gap between academia and industry for realistic, innovative answers needed in …
Apeikon has been accepted into the Alderley Park Accelerator programme. This 8-week programme supports early stage and growing life science business on their journey to success
Apeikon is part of the The Innovators Club 2021, as supported by the Science Entrepreneur Club. This 4-month programme is expertly designed to support the goals and growth of selected …
Apeikon is extremely pleased to be declared the General track and Overall winners of the MIT Enterprise Forum (Greece) Start-up Competition 2021. See: https://www.facebook.com/watch/?v=212443407457451